Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Benchtop Vibration Isolation Is Lightweight

June 1, 2010 5:55 am | Kinetic Systems, Inc. | Product Releases | Comments

Designed for portability, the Ergonomic Low-Profile-Format (ELpF) benchtop platform can be easily repositioned, even with a load and in float.

Only 5 percent of cancer research funds are spent on metastases, yet it kills 90 percent of all cancer patients

June 1, 2010 5:43 am | by EurekAlert | News | Comments

(ECCO-the European CanCer Organisation) On average, about 5 percent of total cancer research funding is spent on investigating metastases (the spread of cancer cells around the body) in Europe, yet metastatic disease is the direct or indirect cause of 90 percent of all cancer...

TOPICS:

Making enough red blood cells

June 1, 2010 5:43 am | by EurekAlert | News | Comments

(European Molecular Biology Laboratory) Two small molecules ensure enough red blood cells are produced, scientists at EMBL Monterotondo and EMBL-EBI found in a study published today in the Journal of Experimental Medicine.

TOPICS:
Advertisement

Isolation Valves Reduce Cost of Fluid Handling

June 1, 2010 5:28 am | Product Releases | Comments

All wetted parts in BCF’s isolation valves are constructed from non-metallic, inert materials to eliminate contamination of the fluid stream through the valve.

Alcohol consumption in Portugal: The burden of disease

June 1, 2010 4:45 am | by EurekAlert | News | Comments

(Alcoholism: Clinical & Experimental Research) Portugal is currently ranked eighth in the world in alcohol consumption. A new study has examined the costs that alcohol consumption has on Portugal's health system. Findings show that roughly 3.8 percent of deaths are attributable to alcohol.

TOPICS:

Embargoed news from Annals of Internal Medicine

June 1, 2010 4:45 am | by EurekAlert | News | Comments

(American College of Physicians) Below is information about three articles and one clinical observation being published in the June 1 issue of Annals of Internal Medicine. The information is not intended to substitute for articles as sources of information. Annals of Internal...

TOPICS:

Lack of private insurance contribute to higher deaths among black heart transplant patients

June 1, 2010 4:44 am | by EurekAlert | News | Comments

(Johns Hopkins Medical Institutions) Transplant surgeons at Johns Hopkins who have reviewed the medical records of more than 20,000 heart transplant patients say that it is not simply racial differences, but rather flaws in the health care system, along with type of insurance and...

TOPICS:

Hopes for breast cancer vaccine

June 1, 2010 4:44 am | by BBC | News | Comments

US scientists say they have developed a vaccine which prevents breast cancer in mice. and they plan trials in humans.

TOPICS:
Advertisement

Pivotal data for the investigational treatment PSD502 for primary premature ejaculation

June 1, 2010 4:44 am | by EurekAlert | News | Comments

(HealthStar PR) Data summarizing the results of two pivotal studies of the investigational new drug, PSD502, a topical metered dose spray being developed for the treatment of primary premature ejaculation. These data were presented at the 2010 American Urological Association Annual...

TOPICS:

Hitachi, Osaki collaborate on smart grid

June 1, 2010 4:44 am | by I-Micronews | News | Comments

Hitachi Ltd and Osaki Electric Co. Ltd have agreed to form a cooperative alliance in the smart grid-related business, including providing solutions based on Advanced Metering Infrastructure (AMI) in the global market.

Fraunhofer IZM-ASSID Selects EV Group Temporary Bonding and Debonding Equipment for Developing Processes for High-Volume Manufacturing of 3D ICs

June 1, 2010 4:44 am | by I-Micronews | News | Comments

EVG Systems Selected for Platform Flexibility, Functionality and Industry-Proven Reliability

MediSapiens Gets $ 1 Million for World's First Personalized Cancer Medicine Software

June 1, 2010 4:43 am | by Bio-Medicine.Org | News | Comments

HELSINKI , June 1, 2010 /- MediSapiens, world's first software company for personalized cancer medicine in oncology clinics and drug development, completed $ 1 million ( EUR 0.8 million ) seed round investment from Veraventure, ETFIII advised by Eqvitec Partners, VTT Ventures and Lifeline...

TOPICS:

Neural Stimulation for Autoimmune Diseases

June 1, 2010 4:42 am | by Massachusetts Institute of Technology | News | Comments

A startup is developing an implanted stimulator to treat such illnesses as arthritis and inflammatory bowel diseases.

TOPICS:

NeuroDerm Successfully Completes Enrollment and Dosing in a Phase 1 Clinical Study of ND0611 Dermal Patch for Parkinson's Disease

June 1, 2010 4:42 am | by Bio-Medicine.Org | News | Comments

NESS ZIONA, Israel , June 1, 2010 /- NeuroDerm, Ltd. announced today the successful enrollment and dosing in its Phase I clinical trial of ND0611. ND0611, a proprietary drug formula administered via a dermal patch, is designed to maintain continuous therapeutic levodopa concentrations for...

TOPICS:

OrthoDynamix Releases New Product

June 1, 2010 4:41 am | by Bio-Medicine.Org | News | Comments

JACKSONVILLE, Fla. , June 1 /- OrthoDynamix announces a line extension to their sports medicine portfolio.  The ArthroSteer Biter is the first ever disposable biter used for meniscal shoulder and knee repair.  A sharp jaw for every procedure affords the ultimate tissue...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading